Skip to main content

Teva Pharmaceutical Industries ADR(TEVA-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Teva Pharmaceutical Industries ADR

124 DVORA HANEVI'a STREET
TEL AVIV L3 6944020 ISR
P: 972-3914-8213
http://www.tevapharm.com

Profile

Teva Pharmaceutical Industries Limited is a global pharmaceutical company that develops, manufactures, and markets both branded and generic drugs, as well as active pharmaceutical ingredients in North America, Europe, Latin America, India, and Israel. Teva's generic product portfolio includes tablets, capsules, liquids, ointments, creams, liquids, injectables, and inhalants. The company's branded products include Copaxone, Austedo, respiratory products like ProAir and Qvar and Ajovy. Teva operates through three segments, North America, Europe and International Markets, each of which includes generics, specialty and over-the-counter products. Teva acquired Allergan's generics business Actavis Generics. The company also acquired Allergan's Anda Inc. Teva acquired Auspex Pharmaceuticals and Barr. Teva has strengthened its position in Europe through its acquisition of Germany's second largest generics producer, ratiopharm.

Key Executives

NameTitle
Mark SabagExecutive VP, Divisional
Richard D. FrancisCEO/Director/President
Richard DaniellExecutive VP, Geographical
David R. McAvoyChief Legal Officer/Executive VP
Eric DrapeExecutive VP, Divisional
Eli KalifCFO/Executive VP
Eric A HughesChief Medical Officer/Executive VP, Divisional
Angus GrantExecutive VP, Divisional
Vikki L. ConwayOther Corporate Officer
Christine FoxExecutive VP, Geographical